Seminars in Diagnostic Pathology
Volume 24, Issue 2 , Pages 89-97 , May 2007

Medicolegal liability in surgical pathology: a consideration of underlying causes and selected pertinent concepts

  • Mark R. Wick, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Mark R. Wick, MD, Room 3020, University Hospital, University of Virginia Medical Center, 1215 Lee Street, Charlottesville, VA 22908-0214.

References 

  1. Davis GG. Malpractice in pathology: what to do when you are sued. Arch Pathol Lab Med. 2006;130:975–978
  2. Troxel DB, Sabella DJ. Problem areas in pathology practice: uncovered by a review of malpractice claims. Am J Surg Pathol. 1994;18:821–831
  3. Troxel DB. Diagnostic pitfalls in surgical pathology: discovered by a review of malpractice claims. Int J Surg Pathol. 2001;9:133–136
  4. Troxel DB. Diagnostic errors in surgical pathology uncovered by a review of malpractice claims (Part I. General considerations). Int J Surg Pathol. 2000;8:161–163
  5. Troxel DB. Error in surgical pathology. Am J Surg Pathol. 2004;28:1092–1095
  6. Troxel DB. An insurer’s perspective on error and loss in pathology. Arch Pathol Lab Med. 2005;129:1234–1236
  7. Troxel DB. Medicolegal aspects of error in pathology. Arch Pathol Lab Med. 2006;130:617–619
  8. AAP Committee on Medical Liability. Malpractice claim review offers mixed news for pediatricians. AAP News. 2001;18:154
  9. Hanzlick R. Lawsuits against medical examiners or coroners arising from death certificates. Am J Forensic Med Pathol. 1997;18:119–123
  10. Troxel DB. Diagnostic errors in surgical pathology uncovered by a review of malpractice claims (Part IV. Melanoma). Int J Surg Pathol. 2001;9:61–63
  11. Troxel DB. Pitfalls in the diagnosis of malignant melanoma: findings of a risk management panel study. Am J Surg Pathol. 2003;27:1278–1283
  12. Troxel DB. Diagnostic errors in surgical pathology uncovered by a review of malpractice claims (Part III. Breast biopsies). Int J Surg Pathol. 2000;8:335–337
  13. Troxel DB. Diagnostic errors in surgical pathology uncovered by a review of malpractice claims (Part VI. Urinary bladder and branchial cleft cyst). Int J Surg Pathol. 2001;9:227–229
  14. Troxel DB. Diagnostic errors in surgical pathology uncovered by a review of malpractice claims (Part VII. Random errors). Int J Surg Pathol. 2001;9:305–308
  15. Hollensead SC, Lockwood WB, Elin RJ. Errors in pathology and laboratory medicine: consequences and prevention. J Surg Oncol. 2004;88:161–181
  16. Renshaw AA, Gould EW. Measuring errors in surgical pathology in real-life practice: defining what does and does not matter. Am J Clin Pathol. 2007;127:144–152
  17. Kronz DJ, Westra WH, Epstein JI. Mandatory second-opinion surgical pathology at a large referral hospital. Cancer. 1999;86:2426–2538
  18. Foucar E. Classification of error in anatomic pathology: a proposal based on an evidence-based standard. Semin Diagn Pathol. 2005;22:139–146
  19. Foucar E. Error in anatomic pathology. Am J Clin Pathol. 2001;116(suppl):S34–S46
  20. Frable WJ. Surgical pathology: second reviews, institutional reviews, audits, and correlations: what’s out there? (Error or diagnostic variation?). Arch Pathol Lab Med. 2006;130:620–625
  21. Nakhleh RE. Error reduction in surgical pathology. Arch Pathol Lab Med. 2006;130:630–632
  22. Henriksen K, Dayton E. Organizational silence and hidden threats to patient safety. Health Serv Res. 2006;41:1539–1554
  23. Wieman TJ, Wieman EA. A systems approach to error prevention in medicine. J Surg Oncol. 2004;88:115–121
  24. Stawicki E: Capping the cost of pain and suffering. Available at: http://news.minnesota.publicradio.org/features/2003/04/25_stawickie_paincap/. Accessed December 22, 2006.
  25. Condel JL, Sharbaugh DT, Raab SS. Error-free pathology: applying lean production methods to anatomic pathology. Clin Lab Med. 2004;24:865–899
  26. Silverberg SG, Wick MR. General philosophy and principles of surgical pathology and cytopathology, including quality and malpractice issues. In:  Silverberg SG, et al. editor. Silverberg’s Principles & Practice of Surgical Pathology & Cytopathology. (ed 4). New York, NY: Churchill-Livingstone; 2006;p. 3–14
  27. Legal definition of “agent”. Available at: http://www.lectlaw.com/def2/s007.htm. Accessed December 27, 2006.
  28. Weedon D. Whither pathology in medical education?. Med J Austr. 2003;178:200–202
  29. Raab SS, Grzybicki DM, Janosky JE, et al. Clinical impact and frequency of anatomic pathology errors in cancer diagnoses. Cancer. 2005;104:2205–2213
  30. Glusac EJ. Under the microscope: doctors, lawyers, and melanocytic neoplasms. J Cutan Pathol. 2003;30:287–293
  31. Raab SS. Variability of practice in anatomic pathology and its effect on patient outcome. Semin Diagn Pathol. 2005;22:177–185
  32. Abt AB, Abt LG, Olt GJ. The effect of interinstitution anatomic pathology consultation on patient care. Arch Pathol Lab Med. 1995;119:514–517
  33. Tsung JS. Institutional pathology consultation. Am J Surg Pathol. 2004;28:399–402
  34. Gupta D, Layfield LJ. Prevalence of interinstitutional anatomic pathology slide review: a survey of current practice. Am J Surg Pathol. 2000;24:280–284
  35. Randall RL, Bruckner JD, Papenhausen MD, et al. Errors in diagnosis and margin determination of soft tissue sarcomas initially treated at non-tertiary centers. Orthopedics. 2004;27:212
  36. Edwards C. Development of a surgical case review system. QRB Qual Rev Bull. 1988;14:332–335
  37. Weiss SW, Willis J, Jansen J, et al. Frozen section consultation: utilization patterns and knowledge base of surgical faculty at a university hospital. Am J Clin Pathol. 1995;104:294–298
  38. Wick MR. Intraoperative consultations in pathology: a current perspective. Am J Clin Pathol. 1995;104:239–242
  39. Ku NN. Pathologic examination of sentinel lymph nodes in breast cancer. Surg Oncol Clin North Am. 1999;8:469–479
  40. Raab SS, Grzybicki DM. Anatomic pathology workload and error. Am J Clin Pathol. 2006;125:809–812
  41. Parker-Pope T. Risk of error may justify second opinion on pathology reports. Wall Street Journal 1. 2001;April 13
  42. Bachner P. College of American Pathologists responds to ABC news segment on medical errors. CAP Today 1. 2001;May 14
  43. Foucar E. Diagnostic decision-making in anatomic pathology. Am J Clin Pathol. 2001;116(suppl):S21–S33
  44. Howanitz PJ, Walker R, Bachner P. Quantification of errors in laboratory reports: a quality improvement study of the College of American Pathologists’ Q-probes program. Arch Pathol Lab Med. 1992;116:694–700
  45. Iezzoni JC, Mills SE. “Undifferentiated” small round cell tumors of the sinonasal tract: differential diagnostic update. Am J Clin Pathol. 2005;124(suppl):S110–S121
  46. Davin JC, Weening JJ. Diagnosis of Henoch-Schoenlein purpura: renal or skin biopsy?. Pediatr Nephrol. 2003;18:1201–1203
  47. Nakhleh RE. What is quality in surgical pathology?. J Clin Pathol. 2006;59:669–672
  48. Wick MR, Archer JB, Isaacs HM, et al. Distribution of surgical pathology reports by a computer-driven facsimile (FAX) device. Semin Diagn Pathol. 1994;11:258–262
  49. Mafee MF, Raofi B, Kumar A, et al. Glomus faciale, glomus jugulare, glomus tympanicum, glomus vagale, carotid body tumors, and simulating lesions: role of magnetic resonance imaging. Radiol Clin North Am. 2000;38:1059–1076
  50. Rettig AC, Strickland JW. Glomus tumor of the digits. J Hand Surg. 1977;2:261–265
  51. Magro CM, Crowson AN, Kovatich AJ, et al. Drug-induced reversible lymphoid dyscrasia: a clonal lymphomatoid dermatitis of memory and activated T-cells. Hum Pathol. 2003;34:119–129
  52. Ritter JH, Wick MR, Adesokan PN, et al. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy-chain gene rearrangement. Am J Clin Pathol. 1997;108:60–68
  53. O’Sullivan MJ, Ritter JH, Humphrey PA, et al. Lymphoid lesions of the gastrointestinal tract: a histologic, immunophenotypic, and genotypic analysis of 49 cases. Am J Clin Pathol. 1998;110:471–477
  54. Renshaw AA, Gould EW. Measuring the value of review of pathology material by a second pathologist. Am J Clin Pathol. 2006;125:737–739
  55. Legal definition of “due diligence”. Available at: http://legal-dictionary.thefreedictionary.com/Due+diligence. Accessed December 27, 2006.
  56. Medical definition of “delayed diagnosis”. Available at: http://www.wrongdiagnosis.com/medical-malpractice/delayed_diagnosis.htm. Accessed December 27, 2006.
  57. Wick MR, Bourne TD, Patterson JW, et al. Evidence-based principles and practices in pathology: selected problem areas. Semin Diagn Pathol. 2005;22:116–125
  58. Colpaert C, Vermeulen P, Jeuris W, et al. Early distant relapse in “node-negative” breast cancer patients is not predicted by occult axillary lymph node metastases, but by the features of the primary tumor. J Pathol. 2001;193:442–449
  59. Martelli G, Miceli R, De Palo G, et al. Is axillary lymph node dissection necessary in elderly patients with breast carcinomas who have a clinically-uninvolved axilla?. Cancer. 2003;97:1156–1163
  60. Pharis DB, Zitelli JA. The management of regional lymph nodes in cancer. Br J Dermatol. 2003;149:919–925
  61. Boman BM, Moertel CG, O’Connell MJ, et al. Carcinoma of the anal canal: a clinical and pathologic study of 188 cases. Cancer. 1984;54:114–125
  62. Nguyen TH. Mechanisms of metastasis. Clin Dermatol. 2004;22:209–216
  63. Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: an integrated review. Curr Mol Med. 2003;3:659–671
  64. Bogenrieder T, Herlyn M. Axis of evil: molecular mechanisms of cancer metastasis. Oncogene. 2003;29:6524–6536
  65. Barbour A, Gotley DC. Current concepts of tumor metastasis. Ann Acad Med Singapore. 2003;32:176–184
  66. Carlson JA. Tumor doubling time of cutaneous melanoma and its metastasis. Am J Dermatopathol. 2003;25:291–299
  67. Leiter U, Meier F, Schittek B, et al. The natural course of cutaneous melanoma. J Surg Oncol. 2004;86:172–178
  68. Andrews BT, Bates T. Delay in the diagnosis of breast cancer: medicolegal implications. Breast. 2000;9:223–237
  69. McKenna DB, Lee RJ, Prescott RJ, et al. The time from diagnostic excisional biopsy to wide local excision for primary cutaneous melanoma may not affect patient survival. Br J Dermatol. 2002;147:48–54
  70. Slingluff CL, Vollmer RT, Reintgen DS, et al. Lethal “thin” malignant melanoma: identifying patients at risk. Ann Surg. 1988;208:150–161
  71. Kalady MF, White RR, Johnson JL, et al. Thin melanomas: predictive lethal characteristics from a 30-year experience. Ann Surg. 2003;238:528–535
  72. Thames HD, Buchholz TA, Smith CD. Frequency of first metastatic events in breast cancer: implications for sequencing of systemic and local-regional treatment. J Clin Oncol. 1999;17:2649–2658
  73. Joshi MG, Lee AK, Loda M, et al. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer. 1996;77:490–498
  74. Schmidt-Ulrich R. Local tumor control and survival: clinical evidence and tumor biologic basis. Surg Oncol Clin North Am. 2000;9:401–414
  75. Bertuzzi A, Gandofi A, Sinisgalli C, et al. Cell loss and the concept of potential doubling time. Cytometry. 1997;29:34–40
  76. Shyu RY, Jiang SY, Jong YJ, et al. Establishment and characterization of a human gastric carcinoma cell line TMC-1. Cells Tissues Organs. 2004;177:37–46
  77. Legant P. Oncologists and medical malpractice. J Oncol Pract. 2006;2:164–169
  78. Vickers AJ, Bianco FJ, Boorjian S, et al. Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?. Cancer. 2006;106:576–580
  79. Hardin C, Pommier S, Pommier RF. The relationship among clinician delay of diagnosis of breast cancer and tumor size, nodal status, and stage. Am J Surg. 2006;192:506–508
  80. Zaren HA. Delay in diagnosis of breast cancer: fact, fiction, or lawyers’ folly?. Curr Surg. 2002;59:8–12
  81. Barber MD, Jack W, Dixon JM. Diagnostic delay in breast cancer. Br J Surg. 2004;91:49–53
  82. Bozcuk H, Martin C. Does treatment delay affect survival in non-small-cell lung cancer? (A retrospective analysis from a single UK center). Lung Cancer. 2001;34:243–252
  83. Brochez L, Verhaeghe E, Bleyen L, et al. Time delay and related factors in the diagnosis of cutaneous melanoma. Eur J Cancer. 2001;37:843–848
  84. Schmnid-Wendtner MH, Baumert J, Stange J, et al. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res. 2002;12:389–394
  85. Legal definition of “tort components”. Available at: http://www.injuryboard.com/view.cfml/Topic=15. Accessed December 27, 2006.
  86. American Joint Committee on Cancer On-Line Collaborative Cancer Staging Manual. Available at: http://www.cancerstaging.org/. Accessed December 27, 2006.
  87. Bianco FJ, Wood DP, Cher ML, et al. Ten-year survival after radical prostatectomy: specimen Gleason score is the predictor in organ-confined prostate cancer. Clin Prostate Cancer. 2003;1:242–247
  88. Okugawa H, Yamamoto D, Uemura Y, et al. Prognostic factors in breast cancer: the value of the Nottingham prognostic index for patients treated in a single institution. Surg Today. 2005;35:907–911
  89. Colozza M, Azambuja E, Cardoso F, et al. Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?. Ann Oncol. 2005;16:1723–1739
  90. Dacic S. Molecular profiling of lung carcinoma: identifying clinically-useful tumor markers for diagnosis and prognosis. Exp Rev Mol Diagn. 2007;7:77–86
  91. Rothwell PM, Mehta Z, Howard SC, et al. From subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet. 2005;365:256–265
  92. Viola D, Bertaccini A, Comerci F, et al. Uro-gramma: the importance of updating the predictive model. Arch Ital Urol Androl. 2004;76:19–24
  93. Gross E. Medical concepts related to individual risk are better explained with “plausibility” rather than “probability”. BMC Cardiovasc Dis. 2005;5:31–36
  94. On-line reference site for litigation on cancer cases. Available at: http://www.mbbf.com/CM/Booksandarticles/Cancer-Litigation.asp#Liability%20Theories. Accessed December 27, 2006.
  95. Rutgers EJ, Peterse HL. Future prospects for the staging of breast cancer. Semin Surg Oncol. 1996;12:3–11
  96. Yarbro JW, Page DL, Fielding LP, et al. American Joint Committee on Cancer prognostic factors consensus conference. Cancer. 1999;86:2436–2446

PII: S0740-2570(07)00045-7

doi: 10.1053/j.semdp.2007.03.003

Seminars in Diagnostic Pathology
Volume 24, Issue 2 , Pages 89-97 , May 2007

Article Tools